cytarabine

Do not receive cytarabine without telling your doctor if you are pregnant.

This list is not complete and there may be other drugs that can interact with cytarabine.

Do not receive a "live" vaccine while you are being treated with cytarabine.

Your doctor will watch you closely when you are given cytarabine.

Other side effects that are common with cytarabine include:

Your pharmacist can provide more information about cytarabine.

Cytarabine should be used only under the supervision of a medical oncologist or hematologist.

It is testing midostaurin in combination with daunorubicin and cytarabine.

All energy then turned to a search of the available literature to see what effects a double dose of Cytarabine would have on the child.

To apply these observations clinically, patients were first treated with cytarabine and daunorubicin.

It is the biologically active form of cytarabine.

In those patients who responded to low-dose cytarabine, response appeared to be caused by a cytotoxic effect of the drug.

Such therapy includes the drugs used in induction and often includes high-dose cytarabine.

Several treatment approaches have been used, including exchange transfusion, leukapheresis, and low-dose cytarabine.

It is not known whether cytarabine passes into breast milk or if it could harm a nursing baby.

Sea to Ara C An essay on the history of cytarabine.

Therefore, treatment with cytarabine is not recommended (DI).

Contact your doctor for instructions if you miss an appointment for your cytarabine injection.

And yet somehow a pharmacist had misread a confusing recipe card for Cytarabine, a drug used to fight leukemia.

Cytarabine interferes with the growth of cancer cells and slows their growth and spread in the body.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely use cytarabine:

Other alternative induction regimens, including high-dose cytarabine alone or investigational agents, may also be used.

Course B consists of methotrexate and cytarabine.

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection.

The cytostatic cytarabine inhibits the antimycotic activity of flucytosine.